Search

everythinglearnresearchcommunity

for

Search:↓

Stem cells compete for space using cell adhesion, and mutations can affect their competitive success, with implications for tissue health and disease.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

Baricitinib is effective for severe alopecia areata but has some side effects.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Abrocitinib helped a 14-year-old girl with severe alopecia areata regrow her hair significantly.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Baricitinib significantly improves nail and hair symptoms in severe alopecia areata.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

A combination of ixekizumab and tofacitinib successfully treated severe scalp cellulitis, leading to hair regrowth.

Ruxolitinib helped regrow hair in a woman with a blood disorder and complete hair loss.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Naringin may help treat atopic dermatitis by reducing inflammation and improving the skin barrier.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

A 22-year-old man has alopecia areata, an autoimmune hair loss condition, with various treatments available.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

The Hedgehog Signaling Pathway is important for skin and hair development and skin cancer treatment, but more research is needed to understand it fully.

Lactate production is important for activating hair growth stem cells.

Vitiligo treatment requires a personalized mix of therapies to restore skin color and improve life quality.

Natural small molecules can help treat diseases by activating or inhibiting the Wnt pathway.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.